Skip to main content
Elizabeth Connick, MD, Infectious Disease, Tucson, AZ, Banner - University Medical Center Tucson

ElizabethConnickMD

Infectious Disease Tucson, AZ

Professor, Medicine, University of Colorado School of Medicine

Dr. Connick is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Connick's full profile

Already have an account?

Education & Training

  • University of Colorado
    University of ColoradoFellowship, Infectious Disease, 1991 - 1994
  • New York Presbyterian Hospital (Columbia Campus)
    New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 1988 - 1991
  • Harvard Medical School
    Harvard Medical SchoolClass of 1988

Certifications & Licensure

  • AZ State Medical License
    AZ State Medical License 2016 - 2024
  • CO State Medical License
    CO State Medical License 1992 - 2017
  • American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Post-Treatment Controllers Identified from 14 Clinical Studies  
    Elizabeth Connick, Michael C Sneller, Jonathan Z Li, Paul Volberding, Daniel R Kuritzkes, Robert T Schooley, David Margolis, Daniel Skiest, John W Mellors, Ronald Mits..., The Journal of Infectious Diseases

Grant Support

  • HIV-1, Exercise And Endothelial FunctionNational Heart, Lung, And Blood Institute2011
  • CTL Exclusion From Lymphoid Follicles As A Mechanism Of Lentivirus Immune InvasioNational Institute Of Allergy And Infectious Diseases2010
  • Sex Differences In Plasma HIV-1 RNA ConcentrationsEunice Kennedy Shriver National Institute Of Child Health &Human Development2006–2010
  • Immunology CoreNational Institute Of Allergy And Infectious Diseases2008
  • Trtmnt Intruptn Amng Sbjts On Potent Antirtroviral Thrpy W/In 16 Dys Of DiagnssNational Center For Research Resources2007–2008
  • Trtmnt W/Tenofovir Df,Emtricitabine,&Lopinavir/Ritonavir VS NO Therapy In HIVNational Center For Research Resources2006–2008
  • Trtmnt W/Lamivudine+Stavudine+Abacavir+Amprenavir/Ritonavir W/Supv InterruptionNational Center For Research Resources2005–2008
  • Acute HIV Infection And Early Disease Research Program (AIEDRP) Core01 Data ProtNational Center For Research Resources2005–2008
  • ACTG A5201(V 20)-Regmin Smplfctn To Atazanavir/Ritonavir Aftr Vrlgc SuppressionNational Center For Research Resources2005–2008
  • Immunopathogenesis Of Acute HIV-1 InfectionNational Institute Of Allergy And Infectious Diseases2004–2007
  • Immune Reconstitution W/Growth Hormin HIV Subjw/Incompcd4+Lymphreston HaartNational Center For Research Resources2005
  • ACTG A5015-Immunologic &Virologic Indices Assoc W/ Aging In Hiv-Infected SubjecNational Center For Research Resources2005
  • Tx W/ Lamivudine+Stavudine+Abacavir+Amprenavir+RitonavirNational Center For Research Resources2004
  • Immune Reconstitution W/ Growth Hormone In HIVNational Center For Research Resources2004
  • Evaluate Ability Of Vaccine-Induced Helper &CtlNational Center For Research Resources2004
  • ACTG A5136-Immune Effect Of Antiretroviral Tx IntensityNational Center For Research Resources2004
  • ACTG A5015-Immunologic &Virologic Indices Assoc W/AgingNational Center For Research Resources2004
  • Cd8+Tcell Antiretroviral Mechanisms In Lymphoid TissueNational Institute Of Allergy And Infectious Diseases2003
  • ACTG 375 Immunologic &Virologic Consequences--Long Term Haart In HIV-1 DISENational Center For Research Resources1999–2002
  • Costimulatory Molecules, CTL, And HIV In Lymphoid TissueNational Institute Of Allergy And Infectious Diseases1998–2002
  • Actg328 Recombinant Human Interleukin 2--Iv Or Subcutaneous AdministrationNational Center For Research Resources1998–2002
  • Autologous Cd4-Zeta Gene-Modified T Cells In HIV Infected PatientsNational Center For Research Resources1997–2000
  • Study Of Safety Of Interleukin-12 In HIV Infected PatientsNational Center For Research Resources1997
  • Lymphopheresis To Determine Yield, Transducility And Growth Of CD8+ CellsNational Center For Research Resources1997
  • Study Of Lymphopheresis To Determine Yield, Transducility And GrowthNational Center For Research Resources1996
  • Rhil12 For HIV Subjects With 100 300 CD4 Cells/Mm3 Of BloodNational Center For Research Resources1996

Hospital Affiliations